Skip to main content

Voigt Michel James's Form 4 filing

Merit Medical Systems IncMMSI · filed Mar 3, 2025

Accession no.
0001415889-25-006307
Filed
Mar 3, 2025
Trade date
Feb 27-28, 2025
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 7 non-derivative transactions and 3 derivative transactions. Open-market sales total $1.38M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Voigt Michel JamesCIK 0001836958Officer (CHIEF HUMAN RESOURCES OFFICER)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 27, 2025Common Stock, No Par ValueAGrant or awardAcquired+11,533$0.00$021,441Direct
Feb 27, 2025Common Stock, No Par ValueFTax withholdingDisposed−4,530$98.50−$446,20516,911Direct
Feb 28, 2025Common Stock, No Par ValueAGrant or awardAcquired+5,488$0.00$022,399Direct
Feb 28, 2025Common Stock, No Par ValueMOption exerciseAcquired+7,261$56.25+$408,431.2529,660Direct
Feb 28, 2025Common Stock, No Par ValueMOption exerciseAcquired+4,048$65.03+$263,241.4433,708Direct
Feb 28, 2025Common Stock, No Par ValueMOption exerciseAcquired+2,500$70.58+$176,45036,208Direct
Feb 28, 2025Common Stock, No Par ValueSSaleDisposed−13,809$99.68F5−$1,376,481.1222,399Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 28, 2025Common StockMOption exerciseDisposed−9,681$0.00$02,420Direct
Feb 28, 2025Common StockMOption exerciseDisposed−8,094$0.00$04,046Direct
Feb 28, 2025Common StockMOption exerciseDisposed−13,576$0.00$011,076Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F5

The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.425 to $100.485, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)